Treatment of Growth Hormone-Deficient Adults with Recombinant Human Growth Hormone Increases the Concentration of Growth Hormone in the Cerebrospinal Fluid and Affects Neurotransmitters
Bengt‐Åke Bengtsson(Sahlgrenska University Hospital), Mats Andersson(Karolinska University Hospital), Anders Lindahl(Medical Products Agency), Lars Hynsjö(Sahlgrenska University Hospital), Anders Elmgren(AstraZeneca (Netherlands)), Sven Lindstedt(Sahlgrenska University Hospital), Per‐Arne Lundberg(Sahlgrenska University Hospital), Göran Larson(University of Gothenburg), Olle Isaksson(University of Gothenburg)
Cited by 205
Related Papers
Treatment of Deep Cartilage Defects in the Knee with Autologous Chondrocyte Transplantation
|New England Journal of Medicine|1994|5.5k
Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
|Proceedings of the National Academy of Sciences|1999|956
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Growth Hormone and Bone*
|Endocrine Reviews|1998|808
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
|The Journal of Clinical Endocrinology & Metabolism|1993|781